Latest filing published 14 Aug 2024 for PROVECTUS BIOPHARMACEUTICALS, INC., €692k.
Insider track record
No signal scores available.
Jeffrey Allen Morris: trading record in brief
All filings by Jeffrey Allen Morris on record concern Provectus Biopharmaceuticals, Inc. Between 8 May 2023 and 12 August 2024, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 14 August 2024, reports a transaction of €692k in Provectus Biopharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey Allen Morris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 264,314 shares@ US$2.86258.5% of flowSeries D-1 Convertible Preferred StockSEC:0001493152-24-032463:0
- 188,757 shares@ US$2.86241.5% of flowSeries D-1 Convertible Preferred StockSEC:0001493152-23-015964:0
2 of 2 declarations